Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2017

Sep 07, 2021

SELL
N/A
-124 Closed
0 $0
Q1 2017

Sep 07, 2021

SELL
N/A
-77 Reduced 38.31%
124 $3,000
Q3 2016

Sep 07, 2021

SELL
N/A
-33 Reduced 14.1%
201 $6,000
Q2 2016

Sep 07, 2021

SELL
N/A
-220 Reduced 48.46%
234 $6,000
Q1 2016

Sep 07, 2021

BUY
N/A
454
454 $16,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $542M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.